Target Name: NIBAN1
NCBI ID: G116496
Review Report on NIBAN1 Target / Biomarker Content of Review Report on NIBAN1 Target / Biomarker
NIBAN1
Other Name(s): FLJ38228 | niban apoptosis regulator 1 | Cell growth inhibiting protein 39 | Protein FAM129A | cell growth-inhibiting gene 39 protein | C1orf24 | Cell growth-inhibiting gene 39 protein | NIBAN | GIG39 | Protein Niban | FAM129A | Niban apoptosis regulator 1 | Protein Niban 1 | NIBA1_HUMAN | family with sequence similarity 129 member A

NIBAN1: A Protein with Broad Implications for Disease

NIBAN1 (FLJ38228) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the NIBAN (Nucleotide-Binding Adaptor) family, which is a family of proteins that play a critical role in the regulation of DNA binding and gene expression.

One of the unique features of NIBAN1 is its ability to interact with small nucleotides, such as cytosine dG and cytosine hU. This interaction allows NIBAN1 to regulate the activity of other proteins and to play a role in a wide range of cellular processes, including DNA replication, transcription, and translation.

In addition to its role in regulating gene expression, NIBAN1 has also been shown to play a critical role in the regulation of cellular signaling pathways. For example, NIBAN1 has been shown to interact with the protein kinase A尾4, which is involved in the regulation of a wide range of cellular processes, including cell signaling, cell survival, and inflammation.

This interaction between NIBAN1 and A尾4 suggests that NIBAN1 may be a potential drug target or biomarker for a variety of diseases, including Alzheimer's disease, Parkinson's disease, and other forms of neurodegenerative disease.

One way to target NIBAN1 is to use small molecules that can modulate its activity. For example, researchers have synthesized a number of small molecules that can interact with NIBAN1 and modulate its activity. These small molecules include inhibitors of DNA binding, modulators of protein kinase , and modulators of DNA replication and transcription.

Another approach to targeting NIBAN1 is to use antibodies that can specifically recognize and label it. This can be a powerful tool for studying the behavior of NIBAN1 in different cellular contexts and for identifying potential drug targets.

In addition to its potential as a drug target or biomarker, NIBAN1 is also of interest as a potential therapeutic agent. Its ability to interact with small nucleotides and its role in the regulation of cellular signaling pathways make it a promising candidate for a variety of therapeutic applications.

Overall, NIBAN1 is a complex and fascinating protein that has important roles in the regulation of DNA binding, transcription, and translation. Its interaction with small nucleotides and its role in the regulation of cellular signaling pathways make it a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand its behavior and its potential as a therapeutic agent.

Protein Name: Niban Apoptosis Regulator 1

Functions: Regulates phosphorylation of a number of proteins involved in translation regulation including EIF2A, EIF4EBP1 and RPS6KB1. May be involved in the endoplasmic reticulum stress response (By similarity)

The "NIBAN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NIBAN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NIBAN2 | NIBAN3 | Nicalin-NOMO complex | NICN1 | Nicotinic (alpha4beta2)2alpha4 receptor | Nicotinic (alpha4beta2)2beta2 receptor | Nicotinic alpha1beta1deltaepsilon Receptor | Nicotinic alpha1beta1deltagamma Receptor | Nicotinic alpha3alpha6beta2 Receptor | Nicotinic alpha3beta2 receptor | Nicotinic alpha3beta2beta3 receptor | Nicotinic alpha3beta4 Receptor | Nicotinic alpha4beta2 receptor | Nicotinic alpha4beta2alpha5 Receptor | Nicotinic alpha4beta4 receptor | Nicotinic alpha6alpha3beta2 Receptor | Nicotinic alpha6alpha3beta2beta3 receptor | Nicotinic alpha6beta2alpha4beta2beta3 receptor | Nicotinic alpha6beta2beta3 receptor | Nicotinic alpha6beta4beta3alpha5 receptor | Nicotinic alpha9alpha10 Receptor | NID1 | NID2 | NIF3L1 | NIFK | NIFK-AS1 | NIHCOLE | NIM1K | NIN | NINJ1 | NINJ2 | NINJ2-AS1 | NINL | NIP7 | NIPA1 | NIPA2 | NIPAL1 | NIPAL2 | NIPAL3 | NIPAL4 | NIPBL | NIPBL-DT | NIPSNAP1 | NIPSNAP2 | NIPSNAP3A | NIPSNAP3B | NISCH | NIT1 | NIT2 | Nitric oxide synthase (NOS) | NKAIN1 | NKAIN1P1 | NKAIN2 | NKAIN3 | NKAIN4 | NKAP | NKAPD1 | NKAPL | NKAPP1 | NKD1 | NKD2 | NKG7 | NKILA | NKIRAS1 | NKIRAS2 | NKPD1 | NKRF | NKTR | NKX1-1 | NKX1-2 | NKX2-1 | NKX2-1-AS1 | NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11